lovastatin has been researched along with Recrudescence in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 24 (77.42) | 18.2507 |
| 2000's | 6 (19.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graça Morais, M; Pedrosa, R; Sena, A | 1 |
| Aguilar, P; Muñoz Díaz, AB | 1 |
| Choudhry, NK; Levin, R; Winkelmayer, WC | 1 |
| Freed, M; Grines, CL; Jones, D; O'Neill, WW; Safian, M; Safian, RD | 1 |
| Drown, DJ | 1 |
| Beigel, Y; Fainaru, M; Gavish, D; Neuman, Y; Teplitzky, Y; Wurzel, M; Zafrir, N | 1 |
| Currier, JW; Faxon, DP | 1 |
| von Pohle, WR | 1 |
| Alexander, RW; Boccuzzi, SJ; Cedarholm, JC; Klein, JL; Kosinski, AS; Stillabower, ME; Talley, JD; Treasure, CB; Weintraub, WS; Zhang, J | 1 |
| Boccuzzi, SJ; Cedarholm, JC; DeMaio, SJ; Ivanhoe, R; King, SB; Klein, JL; Kosinski, AS; Stillabower, ME; Talley, JD; Weintraub, WS | 1 |
| Bonnier, H; Foley, DP; Jackson, G; Macaya, C; Serruys, PW; Shepherd, J; Vrolix, M | 1 |
| Faxon, DP; Franklin, SM | 1 |
| Boccuzzi, SJ; Gilbert, SP; Talley, JD; Weintraub, WS | 1 |
| Camrud, AR; Edwards, WD; Holmes, DR; Jorgenson, MA; Schwartz, RS; Veinot, JP | 1 |
| Cavero, PG; Hartzler, GO; Kacich, RL; Kahn, J; Ligon, R; Maddex, C; McCallister, BD; O'Keefe, JH; Stone, GW | 1 |
| Boccuzzi, SJ; Ghazzal, ZM; King, SB; Klein, L; Kosinski, AS; Waksman, R; Weintraub, WS | 1 |
| Pederson, JP; Weintraub, WS | 1 |
| Avila, PC | 1 |
| Boccuzzi, SJ; Klein, JL; Kosinski, AS; Roehm, JB; Weintraub, WS | 1 |
| Cruz, PD; Garner, LA | 1 |
| de Feyter, PJ | 1 |
| Assmann, G; Breithardt, G; Eckert, S; Fleck, E; Gleichmann, U; Hanrath, P; Kerber, S; Kleemann, A; Lepper, W; Neiss, A; Schernikau, U; von Eckardstein, A | 1 |
| Auch-Schwelk, W; Elsner, M; Mach, S; Schächinger, V; Walter, DH; Zeiher, AM | 1 |
| Dotani, MI; Elnicki, DM; Gibson, CM; Jain, AC | 1 |
| Horlitz, M; Niebauer, J; Sigwart, U | 1 |
| Marchant, B | 1 |
| Alexander, RW; Boccuzzi, SJ; Brown, CL; Cohen, CL; Hirsch, LJ; King, SB; Weintraub, WS | 1 |
| Azrin, MA; Ezekowitz, MD; Gellman, J; Haudenschild, CC; Lerner, E; Nochomowitz, LE; Sarembock, IJ | 1 |
| Ahmad, S | 1 |
| Banka, VS; Maniet, AR; Sahni, R; Voci, G | 1 |
| Keane, PF; Ohri, SK; Sackier, JM; Swift, I; Thompson, GR; Williamson, RC; Wood, CB | 1 |
3 review(s) available for lovastatin and Recrudescence
| Article | Year |
|---|---|
Prevention of post-PTCA restenosis.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Blood Platelets; Calcium; Colchicine; Fish Oils; Humans; Lovastatin; Molsidomine; Oligopeptides; Peptides, Cyclic; Recurrence; Somatostatin; Steroids; Thrombosis | 1995 |
Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Calcium Channel Blockers; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Fish Oils; Humans; Lovastatin; Methylprednisolone; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence | 1993 |
[Statins do not prevent restenosis after coronary angioplasty: where to go from here?].
Topics: Angioplasty, Balloon, Coronary; Animals; Anticholesteremic Agents; Brachytherapy; Cholesterol; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Primary Prevention; Rabbits; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Simvastatin | 2001 |
11 trial(s) available for lovastatin and Recrudescence
| Article | Year |
|---|---|
Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Colchicine; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Enalapril; Female; Humans; Lovastatin; Male; Middle Aged; Pilot Projects; Recurrence | 1995 |
The effect of lovastatin on early restenosis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Double-Blind Method; Exercise Test; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Prospective Studies; Recurrence | 1995 |
Prevention of post-PTCA restenosis.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Blood Platelets; Calcium; Colchicine; Fish Oils; Humans; Lovastatin; Molsidomine; Oligopeptides; Peptides, Cyclic; Recurrence; Somatostatin; Steroids; Thrombosis | 1995 |
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
Topics: Acetylcholine; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Lovastatin; Male; Middle Aged; Nitroglycerin; Prospective Studies; Recurrence; Vasodilation | 1995 |
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
Topics: Angioplasty, Balloon, Coronary; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome | 1994 |
Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Belgium; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Double-Blind Method; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Ireland; Lovastatin; Netherlands; Recurrence; Research Design; Spain; Time Factors; United Kingdom | 1994 |
Costs of coronary restenosis (Lovastatin Restenosis Trial).
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Disease; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Lovastatin; Male; Middle Aged; Prospective Studies; Radiography; Recurrence; Treatment Outcome | 1996 |
Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Constriction, Pathologic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Probucol; Recurrence | 1996 |
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Angiography; Coronary Artery Disease; Diet; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Middle Aged; Prospective Studies; Recurrence; Time Factors | 1999 |
Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Lovastatin; Recurrence | 1992 |
Prevention of restenosis by lovastatin after successful coronary angioplasty.
Topics: Angiography; Angioplasty, Balloon, Coronary; Cholesterol; Coronary Disease; Electrocardiography; Exercise Test; Follow-Up Studies; Humans; Lovastatin; Postoperative Care; Radionuclide Imaging; Recurrence; Thallium | 1991 |
18 other study(ies) available for lovastatin and Recrudescence
| Article | Year |
|---|---|
Therapeutic potential of lovastatin in multiple sclerosis.
Topics: Adult; Disability Evaluation; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Pilot Projects; Recurrence | 2003 |
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Lisinopril; Lovastatin; Male; Nephrotic Syndrome; Prednisone; Recurrence; Verapamil | 2004 |
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
Topics: Aged; Atorvastatin; Chi-Square Distribution; Coronary Disease; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Male; Pravastatin; Proportional Hazards Models; Pyrroles; Recurrence; Retrospective Studies; Simvastatin; Treatment Outcome | 2007 |
Can aggressive efforts directed at lipid lowering post-PTCA reduce the risk of restenosis?
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Humans; Lovastatin; Recurrence | 1995 |
Recurrent hyperthermia due to lovastatin.
Topics: Female; Fever; Humans; Lovastatin; Middle Aged; Recurrence | 1994 |
The effects of lovastatin on neointimal hyperplasia following injury in a porcine coronary artery model.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hyperplasia; Linear Models; Lovastatin; Random Allocation; Recurrence; Single-Blind Method; Swine; Tunica Intima | 1996 |
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Constriction, Pathologic; Coronary Disease; Humans; Lovastatin; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 1996 |
Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Artery Disease; Death, Sudden, Cardiac; Humans; Lovastatin; Myocardial Infarction; Pravastatin; Randomized Controlled Trials as Topic; Recurrence; Scandinavian and Nordic Countries; Simvastatin; Survival Analysis | 1996 |
Prevention of atherosclerosis in coronary-artery bypass grafts.
Topics: Cholesterol, LDL; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Recurrence; Saphenous Vein | 1997 |
Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).
Topics: Aged; Angioplasty, Balloon, Coronary; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 1998 |
Contact puzzle: Worsening of a recurrent facial eruption despite treatment. Diagnosis: allergic contact dermatitis caused by desonide.
Topics: Administration, Topical; Anti-Inflammatory Agents; Anticholesteremic Agents; Desonide; Diagnosis, Differential; Disease Progression; Drug Eruptions; Drug Therapy, Combination; Facial Dermatoses; Female; Glucocorticoids; Humans; Lovastatin; Middle Aged; Patch Tests; Recurrence | 1999 |
Lipids and coronary restenosis:an elusive link.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Disease; Female; Humans; Lipids; Lipoprotein(a); Lipoproteins; Lovastatin; Male; Randomized Controlled Trials as Topic; Recurrence; Risk Factors | 1999 |
Effect of statin therapy on restenosis after coronary stent implantation.
Topics: Anticholesteremic Agents; Atorvastatin; Case-Control Studies; Coronary Angiography; Coronary Disease; Disease-Free Survival; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hyperplasia; Indoles; Lovastatin; Male; Middle Aged; Pyrroles; Recurrence; Retrospective Studies; Simvastatin; Stents; Time Factors; Tunica Intima | 2000 |
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.
Topics: Aged; Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Cause of Death; Coronary Artery Bypass; Coronary Disease; Female; Heart Failure; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Preoperative Care; Pyrroles; Recurrence; Retrospective Studies; Risk Factors; Simvastatin; Stroke; Treatment Outcome | 2000 |
Lovastatin on restenosis.
Topics: Clinical Trials as Topic; Coronary Disease; Drug Costs; Humans; Lovastatin; Recurrence | 1992 |
Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Femoral Artery; Hypercholesterolemia; Hyperplasia; Lovastatin; Male; Muscle, Smooth, Vascular; Rabbits; Recurrence | 1991 |
Lovastatin and nephrotic syndrome.
Topics: Adult; Humans; Hypercholesterolemia; Lovastatin; Male; Nephrotic Syndrome; Recurrence; Remission Induction | 1991 |
Reappraisal of partial ileal bypass for the treatment of familial hypercholesterolemia.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipoproteinemia Type II; Jejunoileal Bypass; Lovastatin; Male; Middle Aged; Recurrence; Reoperation | 1989 |